These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20537804)

  • 1. Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.
    Costine BA; Oberlander JG; Davis MC; Penatti CA; Porter DM; Leaton RN; Henderson LP
    Psychoneuroendocrinology; 2010 Nov; 35(10):1473-85. PubMed ID: 20537804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse.
    Onakomaiya MM; Porter DM; Oberlander JG; Henderson LP
    Horm Behav; 2014 Jul; 66(2):283-97. PubMed ID: 24768711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabolic-androgenic steroid treatment induces behavioral disinhibition and downregulation of serotonin receptor messenger RNA in the prefrontal cortex and amygdala of male mice.
    Ambar G; Chiavegatto S
    Genes Brain Behav; 2009 Mar; 8(2):161-73. PubMed ID: 19055689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse.
    Oberlander JG; Henderson LP
    Neuropsychopharmacology; 2012 May; 37(6):1483-99. PubMed ID: 22298120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat.
    Schlussman SD; Zhou Y; Johansson P; Kiuru A; Ho A; Nyberg F; Kreek MJ
    Neurosci Lett; 2000 Apr; 284(3):190-4. PubMed ID: 10773431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety.
    Sink KS; Walker DL; Freeman SM; Flandreau EI; Ressler KJ; Davis M
    Mol Psychiatry; 2013 Mar; 18(3):308-19. PubMed ID: 22290119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that preimmunization with a heat-killed preparation of Mycobacterium vaccae reduces corticotropin-releasing hormone mRNA expression in the extended amygdala in a fear-potentiated startle paradigm.
    Loupy KM; Arnold MR; Hassell JE; Lieb MW; Milton LN; Cler KE; Fox JH; Siebler PH; Schmidt D; Noronha SISR; Day HEW; Lowry CA
    Brain Behav Immun; 2019 Mar; 77():127-140. PubMed ID: 30597198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
    Walker D; Yang Y; Ratti E; Corsi M; Trist D; Davis M
    Neuropsychopharmacology; 2009 May; 34(6):1533-42. PubMed ID: 19078950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala.
    Choi SH; Kim SJ; Park SH; Moon BH; Do E; Chun BG; Lee MS; Shin KH
    Peptides; 2005 Nov; 26(11):2246-51. PubMed ID: 16269353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety.
    Pomrenze MB; Tovar-Diaz J; Blasio A; Maiya R; Giovanetti SM; Lei K; Morikawa H; Hopf FW; Messing RO
    J Neurosci; 2019 Feb; 39(6):1030-1043. PubMed ID: 30530860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
    Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses.
    Walker DL; Miles LA; Davis M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1291-308. PubMed ID: 19595731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone.
    Toufexis DJ; Davis C; Hammond A; Davis M
    J Neurosci; 2004 Nov; 24(45):10280-7. PubMed ID: 15537900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.
    Lee Y; Davis M
    J Neurosci; 1997 Aug; 17(16):6434-46. PubMed ID: 9236251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amygdalar corticotropin-releasing factor mediates stress-induced anxiety.
    Ventura-Silva AP; Borges S; Sousa N; Rodrigues AJ; Pêgo JM
    Brain Res; 2020 Feb; 1729():146622. PubMed ID: 31881185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Exposure to Androgenic-Anabolic Steroids Exacerbates Axonal Injury and Microgliosis in the CHIMERA Mouse Model of Repetitive Concussion.
    Namjoshi DR; Cheng WH; Carr M; Martens KM; Zareyan S; Wilkinson A; McInnes KA; Cripton PA; Wellington CL
    PLoS One; 2016; 11(1):e0146540. PubMed ID: 26784694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic-androgenic steroid effects on sexual receptivity in ovariectomized rats.
    Blasberg ME; Clark AS
    Horm Behav; 1997 Dec; 32(3):201-8. PubMed ID: 9454671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats.
    Sutherland JE; Burian LC; Covault J; Conti LH
    Pharmacol Biochem Behav; 2010 Dec; 97(2):227-38. PubMed ID: 20709096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus.
    Makino S; Gold PW; Schulkin J
    Brain Res; 1994 Sep; 657(1-2):141-9. PubMed ID: 7820612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.
    Iwasaki-Sekino A; Mano-Otagiri A; Ohata H; Yamauchi N; Shibasaki T
    Psychoneuroendocrinology; 2009 Feb; 34(2):226-237. PubMed ID: 18849120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.